Kras g12c inhibitors and methods of using the same
US-2025381187-A1 · Dec 18, 2025 · US
This page is not indexed by search engines while we improve data quality.
Ma Vu Van patents
Ma Vu Van is listed as an inventor on 30 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ma Vu Van |
| Total patents | 30 |
| First publication | Jan 29, 2015 |
| Latest publication | Dec 18, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
US-12473289-B2 · Nov 18, 2025 · US
KRAS G12C inhibitors and methods of using the same
US-12440491-B2 · Oct 14, 2025 · US
Substituted piperazines as KRAS G12C inhibitors
US-12083121-B2 · Sep 10, 2024 · US
Heterocyclic spiro compounds and methods of use
US-2024059703-A1 · Feb 22, 2024 · US
Kras g12c inhibitors and methods of using the same
US-2024050430-A1 · Feb 15, 2024 · US
Heterocyclic spiro compounds and methods of use
US-2023406860-A1 · Dec 21, 2023 · US
KRAS G12C inhibitors and methods of using the same
US-11766436-B2 · Sep 26, 2023 · US
Novel prmt5 inhibitors
US-2023159510-A1 · May 25, 2023 · US
Kras g12c inhibitors and methods of using the same
US-2022395504-A1 · Dec 15, 2022 · US
Recent patents
Latest publications not already listed above.
Kras g12c inhibitors and methods of using the same
US-2022175782-A1 · Jun 9, 2022 · US
Substituted piperazines as KRAS G12C inhibitors
US-11285156-B2 · Mar 29, 2022 · US
Macrocyclic compounds that inhibit MCL-1 protein
US-11279712-B2 · Mar 22, 2022 · US
KRAS G12C inhibitors and methods of using the same
US-11090304-B2 · Aug 17, 2021 · US
KRAS G12C inhibitors and methods of using the same
US-11053226-B2 · Jul 6, 2021 · US
Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
US-2021171529-A1 · Jun 10, 2021 · US
Macrocyclic compounds that inhibit mcl-1 protein
US-2020247821-A1 · Aug 6, 2020 · US
Kras g12c inhibitors and methods of using the same
US-2020165231-A1 · May 28, 2020 · US
Kras g12c inhibitors and methods of using the same
US-2019374542-A1 · Dec 12, 2019 · US
Kras g12c inhibitors and methods of using the same
US-2019343838-A1 · Nov 14, 2019 · US
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
US-2017267673-A1 · Sep 21, 2017 · US
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
US-9611261-B2 · Apr 4, 2017 · US
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
US-9550762-B2 · Jan 24, 2017 · US
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
US-2016280695-A1 · Sep 29, 2016 · US
Cyclopropyl Fused Thiazin-2-Amine Compounds as Beta-Secretase Inhibitors and Methods of Use
US-2016046618-A1 · Feb 18, 2016 · US
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
US-2015252011-A1 · Sep 10, 2015 · US
TRPM8 antagonists and their use in treatments
US-9096527-B2 · Aug 4, 2015 · US
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
US-9085576-B2 · Jul 21, 2015 · US
Chroman derivatives as TRPM8 inhibitors
US-8952009-B2 · Feb 10, 2015 · US
Chroman derivatives as trpm8 inhibitors
US-2015031668-A1 · Jan 29, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amgen Inc | 31 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D471/04 | 26 |
| A61P35/00 | 18 |
| C07D487/04 | 16 |
| A61K39/39558 | 11 |
| C07D417/14 | 10 |